Abbott Laboratories

ABT · NYSE

Abbott's Medical Devices engine, led by diabetes care, is doing the heavy lifting while Nutrition weakens and the Exact Sciences acquisition adds cancer-diagnostics upside, debt, and integration risk.

Follow Add to Watchlist Ask Question

NYSE ABT Coverage Bootstrap Health Care Medical Devices Diagnostics

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.